The Cancer Genomic Microarray Facility at the Kimmel Cancer Center, Thomas Jefferson University, has selected Febit's Geniom RT analyser for sequencing and microRNA (miRNA) profiling.
The facility aims to use the Geniom RT analyser to advance its biomedical research by proceeding targeted next-generation sequencing (NGS), genome-wide single-nucleotide polymorphism (SNP) and miRNA analysis.
Prof Paolo M Fortina, director, laboratory of cancer genomics at the Kimmel Cancer Center, said: 'My laboratory focuses on the development and validation of technologies for diagnostics with emphasis on SNP detection, mRNA and miRNA profiling in a variety of cancers and other medical conditions.
'The automation and flexibility of Febit's technology allows us to investigate a variety of different diseases in short periods of time.'
